Egg Allergy Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Aimmune Therapeutics, DBV Technologies, ASIT Biotechand Others.

April 15 22:00 2021
Egg Allergy Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Aimmune Therapeutics, DBV Technologies, ASIT Biotechand Others.

Egg Allergy Pipeline

Egg Allergy develops when immune system of the body becomes sensitized and overreacts to proteins in egg whites and/or yolks. When eggs are eaten, the body recognizes the protein as a foreign substance and sends out chemicals to provide protection against it. Those chemicals cause the symptoms of an allergic reaction. According to the experts, about 2 percent of children are allergic to eggs. Although, studies show that about 70 percent of children with an Egg Allergy will recover from the condition by age of16.

DelveInsight’s, Egg Allergy Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Egg Allergy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.


Request for free sample report:


Some of Egg Allergy Companies are:

  • Aimmune Therapeutics
  • DBV Technologies
  • ASIT Biotech
  • And Many Others


Request for free sample report:


Current Egg Allergy Treatment Scenario and Egg Allergy Emerging Therapies:

  • How many companies are developing Egg Allergy drugs?
  • How many Egg Allergy drugs are developed by each company?
  • How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Egg Allergy?
  • What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Egg Allergy therapeutics?
  • What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Egg Allergy and their status?
  • What are the key designations that have been granted to the emerging drugs?


Some of Egg Allergy therapies are:

  • AR201 Powder
  • Viaskin Egg (Egg Allergy Immunotherapy)
  • And Many Others


Request for free sample report:


Table of Contents:


Executive Summary

Egg Allergy: Overview

Pipeline Therapeutics

Therapeutic Assessment

Egg Allergy – DelveInsight’s Analytical Perspective

In-depth Commercial Assessment

  • Egg Allergy companies’ collaborations, Licensing, Acquisition -Deal Value Trends

Egg Allergy Collaboration Deals

Late Stage Products (Phase III)

  • Comparative Analysis

Drug name: Company name

Drug profiles in the detailed report…..

Mid Stage Products (Phase II)

  • Comparative Analysis

AR201: Aimmune Therapeutics

Drug profiles in the detailed report…..

Pre-clinical and Discovery Stage Products

  • Comparative Analysis

Viaskin Egg (Egg Allergy immunotherapy): DBV Technologies

Drug profiles in the detailed report…..

Inactive Products

Egg Allergy Key Companies

Egg Allergy Key Products

Egg Allergy- Unmet Needs

Egg Allergy- Market Drivers and Barriers

Egg Allergy- Future Perspectives and Conclusion

Egg Allergy Analyst Views

Egg Allergy Key Companies


Request for Deatiled TOC:


About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States

Warning: count(): Parameter must be an array or an object that implements Countable in /home/indoreonlinejour/ on line 7